Edoxaban in ACS and Atrial Fibrillation: Risk/Benefit Analysis and Future Directions

Presenter: Michael D. Ezekowitz

REGISTER for free or LOG IN to view this content

Edoxaban in ACS and Atrial Fibrillation: Risk/Benefit Analysis and Future Directions

We Recommend